What is Impladent?
For over three decades, Impladent Ltd. has been a key manufacturer and distributor of advanced regenerative products, focusing on synthetic resorbable bone grafts. Their comprehensive product line, including OsteoGen plugs and various graft accessories, is engineered to optimize dental procedures, prioritizing patient safety and comfort. Impladent serves dental professionals seeking dependable solutions for bone grafting and socket preservation, reinforcing its commitment to advancing oral health.
How much funding has Impladent raised?
Impladent has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
Key Investors in Impladent
PPP
Public-Private Partnership
What's next for Impladent?
The substantial late-stage funding and recent strategic investment signal a pivotal phase for Impladent. This capital infusion is expected to fuel further innovation in their regenerative product portfolio and expand their market reach within the dental sector. The company is poised to leverage this financial backing to enhance its manufacturing capabilities and distribution networks, solidifying its role as a leader in dental regenerative solutions and potentially exploring new therapeutic applications.
See full Impladent company page
